Literature DB >> 18023626

Trace analysis of icariin in human serum with dansyl chloride derivatization after oral administration of Epimedium decoction by liquid chromatography tandem mass spectrometry.

Yinhan Gong1, See Chung Yip, Sennappan Kanagamani Thamarai, Jie Zhang, Hian Kee Lee, E L Yong.   

Abstract

Epimedium herbs are a type of complex traditional Chinese medicine (TCM) with high estrogenic bioactivity. The Epimedium herbal decoction mixture contains many compounds including icariin that can exert potent effects on numerous physiological processes related to human health. An ultrasensitive liquid chromatography tandem mass spectrometric (LC-MS/MS) method has been developed to determine trace levels of icariin in human serum with dansyl chloride derivatization after oral administration of the Epimedium herbal decoctions. The dansyl-icariin showed an intense protonated molecular ion at m/z 910. The collision-induced dissociation of this ion formed a distinctive product at m/z 764, corresponding to a characteristic removal of a rhamnose sugar moiety of icariin. The selected reaction monitoring, based on the m/z 910-->764 transition, was highly specific and ultrasenstive for icariin in human serum samples. The lower limit of quantitation was 10 pg/mL icariin spiked into blank serum. The ranges of coefficients of variation for interday assays and intraday assays were 0-15.0% and 1.1-17.5%, respectively, for a wide linear range from 10 pg/mL to 4 ng/mL. This method was successfully applied to measure trace levels of icariin in a human serum after oral administration of Epimedium decoction within 48 h for the first time.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023626     DOI: 10.1016/j.jchromb.2007.10.045

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Five-year follow-up study of a kidney-tonifying herbal Fufang for prevention of postmenopausal osteoporosis and fragility fractures.

Authors:  Wei-Min Deng; Peng Zhang; Hai Huang; You-Gao Shen; Qin-Hua Yang; Wei-Li Cui; Yang-Shu He; Song Wei; Zhu Ye; Fang Liu; Ling Qin
Journal:  J Bone Miner Metab       Date:  2012-06-22       Impact factor: 2.626

2.  The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.

Authors:  H M Zhu; L Qin; P Garnero; H K Genant; G Zhang; K Dai; X Yao; G Gu; Y Hao; Z Li; Y Zhao; W Li; J Yang; X Zhao; D Shi; T Fuerst; Y Lu; H Li; X Zhang; C Li; J Zhao; Q Wu; S J Zhao
Journal:  Osteoporos Int       Date:  2011-04-20       Impact factor: 4.507

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.